DUBLIN, Ohio — Cardinal Health Inc. plans to acquire cardiology and endovascular device maker Cordis from Johnson & Johnson for $1.944 billion. Cardinal said Monday that the cash deal would significantly advance its offering of interventional cardiology and endovascular solutions for integrated health systems and their patients by giving the company immediate global scale in
Which events were most significant for chain drug retailing in 2014? As usual, that is not an easy question to answer. In many ways, 2014 was a remarkable year for the chain drug industry, one in which the character of the business was changed, probably irrevocably. The industry assumed a global character for perhaps the
CAMP HILL, Pa. — Rite Aid Corp. and McKesson Corp. have expanded their distribution agreement to cover a longer time frame and include both generic and brand-name drugs. The companies said Tuesday that the new five-year agreement runs to March 2019. The deal marks a second extension of Rite Aid and McKesson’s primary distribution relationship.
DUBLIN, Ohio — In a settlement with the Drug Enforcement Agency (DEA), Cardinal Health Inc. has agreed to a two-year suspension of its Lakeland, Fla., distribution center’s registration to ship controlled substances. The pharmaceutical distributor said Tuesday that under the settlement it also has agreed to improve certain anti-diversion procedures. Cardinal noted that the agreement
DUBLIN, Ohio — John Fiacco has been appointed vice president of Medicine Shoppe and Medicap Pharmacies and will take over leadership of both drug store franchises from Terry Burnside, who has stepped down, according to Cardinal Health Inc.DUBLIN, Ohio — John Fiacco has been appointed vice president of Medicine Shoppe and Medicap Pharmacies and will
